Company profile for Bliss Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Bliss Bio is a biopharmaceutical company focusing on the research and development and industrialization of anti-tumor biomacromolecular innovative drugs. Since its establishment, the company has been guided by unmet clinical needs and based on the accumulation of experience in the entire life cycle of innovative drug R&D in the industry . Develop and deploy a differentiated gradient product pipeline of macromolecular bioinnova...
Bliss Bio is a biopharmaceutical company focusing on the research and development and industrialization of anti-tumor biomacromolecular innovative drugs. Since its establishment, the company has been guided by unmet clinical needs and based on the accumulation of experience in the entire life cycle of innovative drug R&D in the industry . Develop and deploy a differentiated gradient product pipeline of macromolecular bioinnovative drugs, establish and improve a variety of product technology platforms and its own production capacity of antibodies and ADCs that meet international GMP standards.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
loor 7, Building 9, Phase III, Heda Yaogu, Qiantang District, Hangzhou City, Z...
Telephone
Telephone
0571-86808367
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Eisai inks Bliss ADC deal to challenge AstraZeneca blockbuster
Eisai inks Bliss ADC deal to challenge AstraZeneca blockbuster

09 May 2023

// Nick Paul Taylor FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/enher-tu-eisai-japanese-drugmaker-inks-bliss-adc-deal-tee-challenge-astrazeneca-blockbuster

Nick Paul Taylor FIERCE BIOTECH
09 May 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty